Oil Surges as Supply Estimates Shrink

Related Link: 

Oil prices soared Monday, marking their strongest three-day rally since Iraq’s 1990 invasion of Kuwait, on doubts the global glut of crude would be as long-lasting as many investors and traders had earlier believed.

New Tallest Skyscraper Planned for Tokyo

Related Link: 

Mitsubishi Estate plans to build what would be Japan’s tallest skyscraper as part of an $8.3 billion development in central Tokyo, the latest sign of a surging property market in the capital.

Iran Deal Could Open Door to Gulf Businesses

Related Link: 

While executives in the Gulf see opportunities, the region’s governments remain at loggerheads on other issues.

Crackdown on Racial Bias Boosts Some Auto-Loan Costs

Related Link: 

A federal regulator’s campaign to fight bias against minorities is changing the way many car loans are priced, a move that is increasing costs for some consumers.

White House Readying Sanctions Plan Against Chinese Firms for Cybertheft

Related Link: 

The White House is readying a menu of sanctions against Chinese state-owned enterprises and private companies that officials believe benefited from the cybertheft of U.S. corporate secrets.

Air Force Official Predicts Private Launches for Military Satellites

Related Link: 

Budget pressures are pushing Pentagon planners to consider outsourcing satellite launches, routine military communication links and even some space-based surveillance operations to industry, a senior Air Force official said.

Samsung Takes Smartwatch Fight to Apple

Related Link: 

Samsung plans to unveil a new smartwatch, as the company attempts to prove that it can outshine Apple on design in a nascent product category.

Stocks End August With Another Loss

Related Link: 

Stocks logged their worst monthly losses in years in August, driven by concerns over China and the timing of a U.S. interest rate rise.

Service Providers See Gold in Shares of Startups

Related Link: 

Branding firm Red Antler is among vendors that are looking to profit on the soaring valuations of young startups by taking payment in stock instead of cash.

Bristol-Myers Granted Right to Buy Promedior

Related Link: 

Bristol-Myers Squibb said that it has been granted the exclusive right to buy privately held Promedior and its experimental fibrosis treatment for up to $1.25 billion.

Syndicate content